BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23231056)

  • 1. Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa.
    Xu Y; Zhang X; Zhao Y; Zhao L; Qiu H; Wu D
    Haemophilia; 2013 Mar; 19(2):e95-6. PubMed ID: 23231056
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune haemophilia in a teenager.
    Batra S; Sharathkumar A; Glaubach T; Gamerman S; Green D
    Haemophilia; 2013 Nov; 19(6):e386-8. PubMed ID: 23992250
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: is there a role for Rituximab and desensitization therapy?
    Gamerman S; Singh AM; Makhija M; Sharathkumar A
    Haemophilia; 2013 Nov; 19(6):e382-5. PubMed ID: 23992223
    [No Abstract]   [Full Text] [Related]  

  • 4. Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?
    Castaman G; Tosetto A
    Haemophilia; 2011 Sep; 17(5):817-8. PubMed ID: 21371198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acquired haemophilia: From registers' data to therapeutic recommendations].
    Lévesque H
    Rev Med Interne; 2013 Jan; 34(1):1-3. PubMed ID: 22998977
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
    Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
    Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
    Cretel E; Jean R; Chiche L; Durand JM
    Geriatr Gerontol Int; 2009 Jun; 9(2):197-9. PubMed ID: 19490140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired haemophilia in a patient with Castleman's disease: a case report.
    Katsuyama T; Sada KE; Katayama A; Hinamoto N; Wakabayashi H; Kawabata T; Makino H
    Haemophilia; 2012 Jul; 18(4):e360-2. PubMed ID: 22630343
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
    Hay CR; Negrier C; Ludlam CA
    Thromb Haemost; 1997 Dec; 78(6):1463-7. PubMed ID: 9423795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy.
    Stemberger M; Möhnle P; Tschöp J; Ney L; Spannagl M; Reincke M
    Haemophilia; 2016 Sep; 22(5):e472-4. PubMed ID: 27480782
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired hemophilia: a clinical experience.
    Mirza MA; Khimani F; Rogers J
    W V Med J; 2010; 106(7):32-5. PubMed ID: 21932489
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA.
    Stockschläder M; Ruf L; Linderer A; Schroeder T; Knoefel WT; Haas R; Giers G; Gerhardt A; Sucker C; Zotz RB; Scharf RE
    Thromb Haemost; 2009 Mar; 101(3):586-90. PubMed ID: 19277426
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgery-associated acquired haemophilia and response to combined rituximab and cyclosporine treatment.
    Kam G; Lee YS; Tan TT; Chow P; Ng HJ
    Haemophilia; 2011 Jul; 17(4):715-6. PubMed ID: 21362110
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia.
    Dehmel H; Werwitzke S; Trummer A; Ganser A; Tiede A
    Haemophilia; 2008 Jul; 14(4):736-42. PubMed ID: 18445011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor eradication with rituximab in haemophilia: where do we stand?
    Franchini M; Mannucci PM
    Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of acquired haemophilia A complicated by peritonitis after distal gastrectomy.
    Sato K; Tsukada N; Inamura J; Kon M; Ito S; Hirai K; Hosoki T
    Haemophilia; 2016 Sep; 22(5):e469-71. PubMed ID: 27457489
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature.
    Biss TT; Velangi MR; Hanley JP
    Haemophilia; 2006 May; 12(3):280-4. PubMed ID: 16643214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.
    Ngo Sack F; Galinat H; Egreteau PY; Mollard LM; Fortin H; Berthou C; Abgrall JF; Pan-Petesch B
    Haemophilia; 2013 Mar; 19(2):e93-4. PubMed ID: 23205641
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant factor VIIa (r-FVIIa) in haemophilia management.
    Rice KM; Savidge GF
    Transfus Sci; 1996 Sep; 17(3):339-40. PubMed ID: 10184611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.